German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …
Europe’s pharmaceutical industry has warned that a review of EU law could undermine the pricing and reimbursement of medicines. The …

The Czech Republic has announced a major healthcare reform plan, including plans to restrict access to high cost new medicines. …
A health minister has confirmed NICE will be “moved” from its current central role in health technology assessment to make …

